AAAAAA

   
Results: 1-21 |
Results: 21
P53 - PROSPECTS FOR CANCER GENE-THERAPY
Authors: SODDU S SACCHI A
Citation: S. Soddu et A. Sacchi, P53 - PROSPECTS FOR CANCER GENE-THERAPY, Cytokines cellular & molecular therapy, 4(3), 1998, pp. 177-185
THE ALPHA-6-BETA-4 INTEGRIN INDUCES P53-DEPENDENT CARCINOMA CELL APOPTOSIS
Authors: BACHELDER RE MARCHETTI A SODDU S MERCURIO AM
Citation: Re. Bachelder et al., THE ALPHA-6-BETA-4 INTEGRIN INDUCES P53-DEPENDENT CARCINOMA CELL APOPTOSIS, Molecular biology of the cell, 9, 1998, pp. 2414-2414
GENOMIC INSTABILITY ASSOCIATED WITH MYOTONIC-DYSTROPHY DOES NOT INVOLVE P53 EXPRESSION AND ACTIVITY
Authors: GENNARELLI M LUCARELLI M AMICUCCI P SODDU S NOVELLI G DALLAPICCOLA B
Citation: M. Gennarelli et al., GENOMIC INSTABILITY ASSOCIATED WITH MYOTONIC-DYSTROPHY DOES NOT INVOLVE P53 EXPRESSION AND ACTIVITY, Cell biochemistry and function, 16(2), 1998, pp. 117-122
WT-P53 ACTION IN HUMAN LEUKEMIA-CELL LINES CORRESPONDING TO DIFFERENTSTAGES OF DIFFERENTIATION
Authors: RIZZO MG ZEPPARONI A CRISTOFANELLI B SCARDIGLI R CRESCENZI M BLANDINO G GIULIACCI S FERRARI S SODDU S SACCHI A
Citation: Mg. Rizzo et al., WT-P53 ACTION IN HUMAN LEUKEMIA-CELL LINES CORRESPONDING TO DIFFERENTSTAGES OF DIFFERENTIATION, British Journal of Cancer, 77(9), 1998, pp. 1429-1438
P53 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - A MARKER OF DISEASE PROGRESSION AND POOR-PROGNOSIS
Authors: CORDONE I MASI S MAURO FR SODDU S MORSILLI O VALENTINI T VEGNA ML GUGLIELMI C MANCINI F GIULIACCI S SACCHI A MANDELLI F FOA R
Citation: I. Cordone et al., P53 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - A MARKER OF DISEASE PROGRESSION AND POOR-PROGNOSIS, Blood, 91(11), 1998, pp. 4342-4349
EXPRESSION OF EXOGENOUS WT-P53 DOES NOT AFFECT NORMAL HEMATOPOIESIS -IMPLICATIONS FOR BONE-MARROW PURGING
Authors: SCARDIGLI R BOSSI G BLANDINO G CRESCENZI M SODDU S SACCHI A
Citation: R. Scardigli et al., EXPRESSION OF EXOGENOUS WT-P53 DOES NOT AFFECT NORMAL HEMATOPOIESIS -IMPLICATIONS FOR BONE-MARROW PURGING, Gene therapy, 4(12), 1997, pp. 1371-1378
ONCOGENES BELONGING TO THE CSF-1 TRANSDUCTION PATHWAY DIRECT P53 TUMOR-SUPPRESSOR EFFECTS TO MONOCYTIC DIFFERENTIATION IN 32D CELLS
Authors: MARTINELLI R BLANDINO G SCARDIGLI R CRESCENZI M LOMBARDI D SACCHI A SODDU S
Citation: R. Martinelli et al., ONCOGENES BELONGING TO THE CSF-1 TRANSDUCTION PATHWAY DIRECT P53 TUMOR-SUPPRESSOR EFFECTS TO MONOCYTIC DIFFERENTIATION IN 32D CELLS, Oncogene, 15(5), 1997, pp. 607-611
P53 REEXPRESSION INHIBITS PROLIFERATION AND RESTORES DIFFERENTIATION OF HUMAN THYROID ANAPLASTIC CARCINOMA-CELLS
Authors: MORETTI F FARSETTI A SODDU S MISITI S CRESCENZI M FILETTI S ANDREOLI M SACCHI A PONTECORVI A
Citation: F. Moretti et al., P53 REEXPRESSION INHIBITS PROLIFERATION AND RESTORES DIFFERENTIATION OF HUMAN THYROID ANAPLASTIC CARCINOMA-CELLS, Oncogene, 14(6), 1997, pp. 729-740
P53 ROLE IN DNA-REPAIR AND TUMORIGENESIS
Authors: SODDU S SACCHI A
Citation: S. Soddu et A. Sacchi, P53 ROLE IN DNA-REPAIR AND TUMORIGENESIS, Journal of experimental & clinical cancer research, 16(3), 1997, pp. 237-242
TERMINALLY DIFFERENTIATED SKELETAL MYOTUBES ARE NOT CONFINED TO G(0) BUT CAN ENTER G(1) UPON GROWTH-FACTOR STIMULATION
Authors: TIAINEN M PAJALUNGA D FERRANTELLI F SODDU S SALVATORI G SACCHI A CRESCENZI M
Citation: M. Tiainen et al., TERMINALLY DIFFERENTIATED SKELETAL MYOTUBES ARE NOT CONFINED TO G(0) BUT CAN ENTER G(1) UPON GROWTH-FACTOR STIMULATION, Cell growth & differentiation, 7(8), 1996, pp. 1039-1050
WILD-TYPE P53 INDUCES DIVERSE EFFECTS IN 32D CELLS EXPRESSING DIFFERENT ONCOGENES
Authors: SODDU S BLANDINO G SCARDIGLI R MARTINELLI R RIZZO MG CRESCENZI M SACCHI A
Citation: S. Soddu et al., WILD-TYPE P53 INDUCES DIVERSE EFFECTS IN 32D CELLS EXPRESSING DIFFERENT ONCOGENES, Molecular and cellular biology, 16(2), 1996, pp. 487-495
LONIDAMINE INDUCES APOPTOSIS IN DRUG-RESISTANT CELLS INDEPENDENTLY OFTHE P53 GENE
Authors: DELBUFALO D BIROCCIO A SODDU S LAUDONIO N DANGELO C SACCHI A ZUPI G
Citation: D. Delbufalo et al., LONIDAMINE INDUCES APOPTOSIS IN DRUG-RESISTANT CELLS INDEPENDENTLY OFTHE P53 GENE, The Journal of clinical investigation, 98(5), 1996, pp. 1165-1173
INTERFERENCE WITH P53 PROTEIN INHIBITS HEMATOPOIETIC AND MUSCLE DIFFERENTIATION
Authors: SODDU S BLANDINO G SCARDIGLI R COEN S MARCHETTI A RIZZO MG BOSSI G CIMINO L CRESCENZI M SACCHI A
Citation: S. Soddu et al., INTERFERENCE WITH P53 PROTEIN INHIBITS HEMATOPOIETIC AND MUSCLE DIFFERENTIATION, The Journal of cell biology, 134(1), 1996, pp. 193-204
THE BETA(4) INTEGRIN SUBUNIT IS EXPRESSED IN MOUSE FIBROBLASTS AND MODULATED BY TRANSFORMING GROWTH FACTOR-BETA(1)
Authors: SCARDIGLI R SODDU S FALCIONI R CRESCENZI M CIMINO L SACCHI A
Citation: R. Scardigli et al., THE BETA(4) INTEGRIN SUBUNIT IS EXPRESSED IN MOUSE FIBROBLASTS AND MODULATED BY TRANSFORMING GROWTH FACTOR-BETA(1), Experimental cell research, 227(2), 1996, pp. 223-229
RETINOIC ACID AND CAMP DIFFERENTIALLY REGULATE HUMAN CHROMOGRANIN-A PROMOTER ACTIVITY DURING DIFFERENTIATION OF NEUROBLASTOMA-CELLS
Authors: GAETANO C MANNI I BOSSI G PIAGGIO G SODDU S FARINA A HELMAN LJ SACCHI A
Citation: C. Gaetano et al., RETINOIC ACID AND CAMP DIFFERENTIALLY REGULATE HUMAN CHROMOGRANIN-A PROMOTER ACTIVITY DURING DIFFERENTIATION OF NEUROBLASTOMA-CELLS, European journal of cancer, 31A(4), 1995, pp. 447-452
WILD-TYPE P53 MODULATES APOPTOSIS OF NORMAL, IL-3 DEPRIVED, HEMATOPOIETIC-CELLS
Authors: BLANDINO G SCARDIGLI R RIZZO MG CRESCENZI M SODDU S SACCHI A
Citation: G. Blandino et al., WILD-TYPE P53 MODULATES APOPTOSIS OF NORMAL, IL-3 DEPRIVED, HEMATOPOIETIC-CELLS, Oncogene, 10(4), 1995, pp. 731-737
THE EFFECTS OF END-POINT OVERDISPERSIONS ON THE VALIDITY OF SINGLE-DOSE TUMORIGENICITY ASSAYS
Authors: LEWIS AM BANKS SM SODDU S COOK JL
Citation: Am. Lewis et al., THE EFFECTS OF END-POINT OVERDISPERSIONS ON THE VALIDITY OF SINGLE-DOSE TUMORIGENICITY ASSAYS, Cancer letters, 93(2), 1995, pp. 179-186
MITOTIC-CYCLE REACTIVATION IN TERMINALLY DIFFERENTIATED CELLS BY ADENOVIRUS INFECTION
Authors: CRESCENZI M SODDU S TATO F
Citation: M. Crescenzi et al., MITOTIC-CYCLE REACTIVATION IN TERMINALLY DIFFERENTIATED CELLS BY ADENOVIRUS INFECTION, Journal of cellular physiology, 162(1), 1995, pp. 26-35
EXOGENOUS WT-P53 EXPRESSION DOES NOT AFFECT THE COLONY-FORMING EFFICIENCY OF NORMAL BONE-MARROW CELLS
Authors: SODDU S SCARDIGLI R BLANDINO G CRESCENZI M SACCHI A
Citation: S. Soddu et al., EXOGENOUS WT-P53 EXPRESSION DOES NOT AFFECT THE COLONY-FORMING EFFICIENCY OF NORMAL BONE-MARROW CELLS, Journal of cellular biochemistry, 1994, pp. 103-103
WILD-TYPE P53 GENE-EXPRESSION INDUCES GRANULOCYTIC DIFFERENTIATION OFHL-60 CELLS
Authors: SODDU S BLANDINO G CITRO G SCARDIGLI R PIAGGIO G FERBER A CALABRETTA B SACCHI A
Citation: S. Soddu et al., WILD-TYPE P53 GENE-EXPRESSION INDUCES GRANULOCYTIC DIFFERENTIATION OFHL-60 CELLS, Blood, 83(8), 1994, pp. 2230-2237
WILD-TYPE-P53 DIFFERENTIALLY AFFECTS TUMORIGENIC AND METASTATIC POTENTIAL OF MURINE METASTATIC CELL VARIANTS
Authors: RIZZO MG SODDU S TIBURSI G CALABRETTA B SACCHI A
Citation: Mg. Rizzo et al., WILD-TYPE-P53 DIFFERENTIALLY AFFECTS TUMORIGENIC AND METASTATIC POTENTIAL OF MURINE METASTATIC CELL VARIANTS, Clinical & experimental metastasis, 11(5), 1993, pp. 368-376
Risultati: 1-21 |